| Old Articles: <Older 29121-29130 Newer> |
|---|
 |
The Motley Fool
March 14, 2008
Brian Orelli |
ALS: The Disease That Kills Drugs Teva's Copaxone doesn't help patients with Lou Gehrig's disease. Investors, take note.   |
The Motley Fool
March 14, 2008
Morgan Housel |
Bear Stearns Hits the Panic Button Investment bank Bear Stearns liquidity woes prove to be true; the bank announces that it will receive short-term financing from the Federal Reserve and rival JPMorgan Chase. |
The Motley Fool
March 14, 2008
Morgan Housel |
Countrywide's Future Is Anyone's Guess With its future riding on a pending merger, legal woes add yet more strain to the mortgage lender. |
The Motley Fool
March 14, 2008
Brian Orelli |
Weighing In on Obesity Drugs Could investing in drugmakers that produce weight-loss drugs help fatten your wallet? |
The Motley Fool
March 14, 2008
Brian Orelli |
No Slowdown for China's WuXi Chinese drug researcher and manufacturer WuXi signs more drug development deals and buys a U.S. manufacturing services company. |
The Motley Fool
March 14, 2008
Todd Wenning |
Up in the Air at Embraer The world's largest manufacturer of commercial jets announces mixed results. |
The Motley Fool
March 14, 2008
Anders Bylund |
EA Puts the Heat on Take-Two Electronic Arts' friendly bid to acquire Take-Two Interactive turns hostile. |
The Motley Fool
March 14, 2008
Alyce Lomax |
Somebody's Snapping Up Crocs A board member buys stock in the trendy shoe manufacturer at current levels. |
The Motley Fool
March 14, 2008
Jim Mueller |
Stock of the Week: Yum! Brands Our profiled stock of the week is Yum! Brands, the biggest fast-food company you've never heard of. |
The Motley Fool
March 14, 2008
Todd Wenning |
Nothing Exotic at Luxottica The weak U.S. dollar and mounting concerns about U.S. consumer spending are hurting the Italian eyeglass manufacturer. |
| <Older 29121-29130 Newer> Return to current articles. |
